Driehaus Capital Management LLC Artivion, Inc. Transaction History

Driehaus Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$25.85 - $30.47 $5.6 Million - $6.6 Million	-216,691 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$25.76 - $34.03 $786,117 - $1.04 Million	-30,517 Reduced 12.34%	216,691 $6.15 Million
Q3 2018 Nov 14, 2018	BUY	$28.6 - $35.75 $2.39 Million - $2.99 Million	83,518 Added 51.02%	247,208 $8.7 Million
Q2 2018 Aug 14, 2018	BUY	$19.4 - $29.35 $152,813 - $231,189	7,877 Added 5.06%	163,690 $4.56 Million
Q1 2018 May 15, 2018	SELL	$16.85 - $22.1 $1.12 Million - $1.46 Million	-66,287 Reduced 29.85%	155,813 $3.12 Million
Q4 2017 Feb 14, 2018	SELL	$18.65 - $23.85 $1.58 Million - $2.01 Million	-84,464 Reduced 27.55%	222,100 $4.25 Million
Q3 2017 Nov 14, 2017	BUY	$18.85 - $23.05 $5.78 Million - $7.07 Million	306,564	306,564 $6.96 Million

181

36M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.23B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.